Relating protein pharmacology by ligand chemistry
暂无分享,去创建一个
Michael J. Keiser | J. Irwin | B. Shoichet | B. Roth | B. Armbruster | P. Ernsberger | Blaine N. Armbruster
[1] J. Kruskal. On the shortest spanning subtree of a graph and the traveling salesman problem , 1956 .
[2] M. Leider. Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .
[3] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[4] Johnz Willett. Similarity and Clustering in Chemical Information Systems , 1987 .
[5] S. Karlin,et al. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[6] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[7] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[8] Krueger Ke. Peripheral-type benzodiazepine receptors: a second site of action for benzodiazepines. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[9] Peripheral-type benzodiazepine receptors: a second site of action for benzodiazepines. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[10] A. D. Hershey,et al. Ligand Binding Kinetics of Substance P and Neurokinin A Receptors Stably Expressed in Chinese Hamster Ovary Cells and Evidence for Differential Stimulation of Inositol 1,4,5‐Trisphosphate and Cyclic AMP Second Messenger Responses , 1992, Journal of neurochemistry.
[11] E. Webb. Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. , 1992 .
[12] P. Krogsgaard‐Larsen,et al. Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord , 1995, Neuroscience Letters.
[13] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[14] L. Limbird,et al. The Three -Adrenergic Receptor Subtypes Achieve Basolateral Localization in Madin-Darby Canine Kidney II Cells via Different Targeting Mechanisms (*) , 1996, The Journal of Biological Chemistry.
[15] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[16] H. Matter,et al. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. , 1997, Journal of medicinal chemistry.
[17] Robert P. Sheridan,et al. A Method for Visualizing Recurrent Topological Substructures in Sets of Active Molecules , 1998, J. Chem. Inf. Comput. Sci..
[18] P. Ernsberger,et al. Muscarinic receptor binding sites of the M4 subtype in porcine lung parenchyma. , 1998, Pharmacology & toxicology.
[19] W. Pearson. Empirical statistical estimates for sequence similarity searches. , 1998, Journal of molecular biology.
[20] Eric Jones,et al. SciPy: Open Source Scientific Tools for Python , 2001 .
[21] Robert P Sheridan,et al. Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.
[22] Bryan L. Roth,et al. Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] Ruedi Stoop,et al. An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design , 2002, J. Chem. Inf. Comput. Sci..
[24] Xin Chen,et al. Performance of Similarity Measures in 2D Fragment-Based Similarity Searching: Comparison of Structural Descriptors and Similarity Coefficients , 2002, J. Chem. Inf. Comput. Sci..
[25] B. Roth,et al. Molecular biology of serotonin receptors structure and function at the molecular level. , 2002, Current topics in medicinal chemistry.
[26] B. Rost. Enzyme function less conserved than anticipated. , 2002, Journal of molecular biology.
[27] Paul Ernsberger,et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[29] William Stafford Noble,et al. Matrix2png: a utility for visualizing matrix data , 2003, Bioinform..
[30] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..
[31] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[32] Soumen Chakrabarti,et al. Similarity and Clustering , 2003 .
[33] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[34] B. Roth,et al. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine’s actions? , 2005, Psychopharmacology.
[35] Peter Willett,et al. Enhancing the Effectiveness of Virtual Screening by Fusing Nearest Neighbor Lists: A Comparison of Similarity Coefficients , 2004, J. Chem. Inf. Model..
[36] John Sharkey,et al. Acquired QT interval prolongation and HERG: implications for drug discovery and development. , 2004, European journal of pharmacology.
[37] M. Vieth,et al. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. , 2004, Biochimica et biophysica acta.
[38] S. Izrailev,et al. Enzyme classification by ligand binding , 2004, Proteins.
[39] C. Yost,et al. Functional Inhibition by Methadone of N-Methyl-d-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects , 2004, Anesthesia and analgesia.
[40] J. Ufkes,et al. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts , 2004, European Journal of Clinical Pharmacology.
[41] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[42] P. Willett. Searching techniques for databases of two- and three-dimensional chemical structures. , 2005, Journal of medicinal chemistry.
[43] Stuart L Schreiber,et al. Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.
[44] M. Ikeda,et al. Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa. , 2005, Journal of pharmacological sciences.
[45] Meir Glick,et al. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..
[46] Ajay N. Jain,et al. Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.
[47] Thierry Langer,et al. Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening , 2006, J. Chem. Inf. Model..
[48] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[49] Jérôme Hert,et al. New Methods for Ligand-Based Virtual Screening: Use of Data Fusion and Machine Learning to Enhance the Effectiveness of Similarity Searching , 2006, J. Chem. Inf. Model..
[50] Andreas Bender,et al. "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..